Genedrive PLC (GDR)
Industry Diagnostics & Research
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
0.90p
Buy
1.10p
0.00p (+0.00%)
Prices updated at 12 Dec 2025, 14:28 GMT
| Prices minimum 15 mins delay
Prices in GBX
Genedrive PLC is a holding company engaged in molecular diagnostics business. The company is organised into operating divisions – Preclinical Research Services, Pharmacogenomic Services, and Diagnostics.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Diagnostics & Research
Chairman
Dr. Ian David Gilham
CEO
Dr. Gino Miele
Most recent earnings
30 Jun 2025
Fiscal year end
30 Jun 2025
Employees
43
Head office
Grafton Street
Manchester
United Kingdom
M13 9XX
Key personnel
Owner name | Salary |
|---|---|
Dr. Ian David Gilham Non-Executive Director, Chairman | - |
Mr. Chris Henry Francis Yates Non-Executive Director | - |
Mr. Thomas Lindsay Non-Executive Director | - |
Mr. Russell John Shaw Executive Director, Chief Financial Officer and Company Secretary | - |
Dr. Gino Miele Executive Director, Chief Executive Officer and Chief Scientific Officer | - |
Top 5 shareholders
Owner name | No. of shares |
|---|---|
| Unicorn Asset Management Ltd | 1,154,697 |
| Unicorn AIM VCT Series 3 ORD | 1,154,697 |
| Octopus Investments Limited | 258,065 |
Director dealings
Date | Action |
|---|---|
| 16 Oct 2025 | Purchase |
| 16 Oct 2025 | Purchase |
| 16 Oct 2025 | Purchase |
| 16 Oct 2025 | Purchase |
| 20 Dec 2024 | Purchase |
| 20 Dec 2024 | Purchase |
| 20 Dec 2024 | Purchase |
| 20 Dec 2024 | Purchase |
Please note that past performance is not a reliable indicator of future returns.
